Orchard Therapeutics

Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.

101-250 employees

Founded 2015

$34M post ipo equity

Biotechnology

Public Company

Website LinkedIn Email Twitter Share Tweet

Biotechnology Health Care Genetics Health Diagnostics

Open Positions2

Remote, Eastern Territory USFull-TimeBiotech, PharmaceuticalPosted

Senior Medical Science Liaison - Gene Therapy US Medical Affairs

Identify, build and maintain collaborative partnerships with healthcare providers (HCP’s) and key external experts such as KOL’s and academic institutions to become a trusted scientific partner.
Provide timely, audience-appropriate information and updates to enhance the understanding of the scientific and medical value of Orchard’s programs.
Maintain training records and deliver training updates to ensure all personnel in assigned Qualified Treatment Centers are appropriately trained according to Orchard’s SOPs and the latest Product Manual.
Develop a territory profile including Centers of Excellence, key expertise, newborn screening approaches and leaders, and market access pathways to inform medical strategy and tactical planning.
Gather insights from the field on data, therapeutic area, and competitive intelligence to help inform company strategies and evidence generation plans.
Build thorough operational understanding to ensure excellence in execution balanced with risk management within the boundaries of all governance processes.
Review and oversee Investigator-Sponsored Trial (IST) requests and Early Access Program (EAP) requests throughout the internal review process and any follow up requests for information.
Build effective internal partnerships through communication and collaboration across the organization.
Ensure compliance with internal and external regulatory and legal guidelines.
Maintain clinical, scientific, and technical expertise in therapeutic area.

Showing 1 of 2 positions

About Orchard Therapeutics

Orchard Therapeutics is a publicly traded, commercial-stage biotechnology company pioneering innovative gene therapies for rare diseases. We've demonstrated sustained clinical benefit in over 150 patients across five disease areas, leveraging our autologous ex vivo gene therapy platform. Our portfolio includes Strimvelis®, the first autologous ex vivo gene therapy approved by the EMA, and several other programs in advanced clinical trials. We collaborate with leading academic institutions globally, bringing together the best minds in gene therapy research and development. Orchard operates in a dynamic and fast-paced environment. Our tech stack includes technologies such as Amazon Web Services (including CloudFront and the Virginia region), Ruby on Rails, and Envoy, showcasing our commitment to leveraging cutting-edge technology to advance our mission. We prioritize a collaborative and results-oriented engineering culture fostering innovation and efficient execution. We are dedicated to transforming the lives of patients with rare diseases and building a company culture of passion, collaboration, and integrity. This commitment extends to our employees, who are key to our success. Our current team of 101-250 employees enjoys a supportive and engaging work environment focused on making a meaningful difference in the lives of others. Orchard Therapeutics has received significant funding, including over $494 million in funding rounds and continues to grow and expand its clinical pipeline. This commitment to innovation positions us for continued growth and leadership in the field of gene therapy.

Tech Stack

widgetsmobileanalyticscms